Plasma Molecular Profiling in ALK Inhibitor Resistant NSCLC
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
MIDRIXNEO-LUNG Dendritic Cell Vaccine in Patients With Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of ARRY-614 Plus Either Nivolumab or Nivolumab+Ipilimumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
I-125 Seeds Implantation in the Treatment of Recurrent Lung Cancer After Radiotherapy
- Status
- RECRUITING
- Phase
- N/A
Marrow Infiltrating Lymphocytes - Non-Small Cell Lung Cancer (MILs™ - NSCLC) Alone or in Combination With Nivolumab With or Without Tadalafil in Locally Advanced and Unresectable or Metastatic NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study to Evaluate the Safety of Nanoxel M Inj.
- Status
- UNKNOWN
- Phase
- N/A
GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE1
Treatment of Non-small Cell Lung Cancer With PD-1 Monoclonal Antibody Combined With Donafenib Toluene Sulfonate
- Status
- UNKNOWN
- Phase
- PHASE1
Study of KN046 With Chemotherapy in First Line Advanced NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2
Biodistribution and Kinetics of 18F-AraG in Non-Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of SGN-CD228A in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Induction of Sensecence Using Dexamethasone to Re-sensitize NSCLC to Anti-PD1 Therapy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Circulating DNA in Surgically Treated NSCLC
- Status
- UNKNOWN
- Phase
- N/A
A Study of Osimertinib With or Without Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor Non-Small Cell Lung Cancer (FLAURA2)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
LMB-100 Followed by Pembrolizumab in the Treatment of Adults With Mesothelin-Expressing Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
- Status
- TERMINATED
- Phase
- PHASE2
Molecular Profiling Project
- Status
- SUSPENDED
- Phase
- N/A
A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers
- Status
- TERMINATED
- Phase
- PHASE1
FDG PET/CT Radiomics Analyses of Lung Cancer Patients Treated With Immunotherapy
- Status
- COMPLETED
- Phase
- N/A